UNITED STATES of America, Plaintiff-Appellee v. Thomas William MALONE, Jr., Defendant-Appellant. United States of America, Plaintiff-Appellee v. Drew T. Green, Defendant-Appellant.
Nos. 14-31426, 15-30011.
United States Court of Appeals, Fifth Circuit.
Dec. 11, 2015.
809 F.3d 251
VACATED and REMANDED in part; AFFIRMED in part.
Steven Howard Sadow, Esq. (argued), Law Office of Steven H. Sadow, P.C., Atlanta, GA, for Defendant-Appellant.
Before JOLLY, HIGGINBOTHAM, and SMITH, Circuit Judges.
PATRICK E. HIGGINBOTHAM, Circuit Judge:
Thomas William Malone, Jr. and Drew T. Green pleaded guilty to one count of conspiracy to distribute and possess with the intent to distribute AM-2201, a controlled substance analogue, in violation of
I.
Thomas William Malone, Jr. and Drew T. Green were the owners of NutraGenomics Mfg L.L.C. Prior to March 2011, NutraGenomics distributed JWH-018 throughout the United States. When new federal and state laws banned this substance, NutraGenomics discontinued its distribution and began selling several new synthetic cannabinoids, one of which was AM-2201. Malone and Green sold AM-2201 both in bulk and as part of a product called “Mr. Miyagi” a mixture of AM-2201 and vegetable material that visually resembled marijuana. Though Mr. Miyagi was, with a wink, labeled as potpourri not fit for human consumption, the expectation was that the user would smoke the product in order to get high off its active ingredient, AM-2201. Malone and Green brought in Boyd A. Barrow and Joshua Espinoza to manufacture and distribute Mr. Miyagi, both now co-defendants. They in turn sold a large quantity of Mr. Miyagi to Richard Buswell, who distributed it at stores throughout Louisiana.
On September 4, 2012, a federal grand jury in the Western District of Louisiana returned a superseding indictment charging Malone, Green, and several co-defendants with one count of conspiracy to distribute and possess with the intent to distribute AM-2201, a controlled substance analogue, one count of conspiracy to introduce and cause to be introduced misbranded drugs into interstate commerce, and one count of conspiracy to commit money laundering. Within about two weeks, Malone and Green had reached plea agreements with the Government in which they agreed to cooperate and plead guilty to the count of conspiracy to distribute AM-2201 in exchange for the dismissal of the remaining counts. They pled guilty to one count of conspiracy to distribute and possess with the intent to distribute a Schedule I Controlled Dangerous Substance, in violation of
The guilty pleas were accepted, and the probation office prepared presentence reports (“PSRs“). Because AM-2201 is not listed in either the Drug Quantity Table or the Drug Equivalency Tables, the PSRs had to “determine the base offense level using the marihuana equivalency of the most closely related controlled substance” to AM-2201.1 The Sentencing Guidelines require that three factors guide this inquiry:
(A) Whether the controlled substance not referenced in this guideline has a chemical structure that is substantially similar to a controlled substance referenced in this guideline.
(B) Whether the controlled substance not referenced in this guideline has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance referenced in this guideline.
(C) Whether a lesser or greater quantity of the controlled substance not referenced in this guideline is needed to produce a substantially similar effect on the central nervous system as a controlled substance referenced in this guideline.2
Appellants objected to the use of a 1:167 ratio to convert the 1400 kilograms of AM-2201 into marijuana. Instead, they argued that a 1:1 ratio was appropriate because marijuana, not THC, is the “most closely related controlled substance” to AM-2201. Alternatively, they asked the district court to exercise its discretion under Kimbrough v. United States6 to reject the 1:167 ratio. These objections prompted an evidentiary hearing. Two experts—one for the Government and one for the defense—testified at length in the hearing about the available scientific data on AM-2201. The Government‘s expert, Dr. Jordan Trecki, relied on five different categories of evidence to support his opinion that THC is the “most closely related substance” to AM-2201: (1) a “binding study” showing that THC and AM-2201 bind to the same cannabinoid receptor; (2) a “functional assay” showing that THC and AM-2201 both activate this receptor; (3) a drug discrimination study showing that (a) rats cannot tell the difference between THC and AM-2201 and that (b) AM-2201 is more potent than THC; (4) a “tetrad study” showing that rats react similarly to THC and JWH-018, an analogue of AM-2201; and (5) case studies showing that THC and AM-2201 have similar effects on human users. The defense expert, Dr. Nicholas Cozzi, devoted much of his testimony to criticizing the evidence relied upon by Dr. Trecki. In particular, Dr. Cozzi criticized Dr. Trecki for relying on animal studies—as opposed to human studies—and combining the results of several different studies—each of which was inconclusive standing alone—to form his opinion. When asked to provide his opinion, Dr. Cozzi remarked that it was “kind of a nonscience question,” but testified that marijuana was the “most closely related controlled substance” to AM-2201 because “it‘s consumed in the same way and it‘s consumed for the same effect.” Both experts agreed, however, that there was no scientific basis for the 1:167 ratio used to convert THC into marijuana.7
The next day, the district court issued an oral ruling on Appellants’ objections. Citing the evidence relied upon by Dr. Trecki, the district court concluded that the Government had demonstrated by a preponderance of the evidence that THC was the “most closely related controlled substance” to AM-2201. The court further declined to rely upon Kimbrough to reject the 1:167 ratio. Though acknowledging that “the ratios in the sentencing guidelines are often arbitrary,” the district
II.
Appellants raise five claims of sentencing error: (1) the district court erred in concluding that THC is the “most closely related controlled substance” to AM-2201; (2) the district court did not recognize its discretion under Kimbrough v. United States8 to vary from the 1:167 ratio for converting THC into marijuana; (3) the district court considered non-assistance-related factors in reducing the extent of their § 5K1.1 departures; (4) the district court awarded unreasonably small § 5K1.1 departures; and (5) the district court erred in balancing the
A.
Malone and Green challenge the district court‘s conclusion that THC is the “most closely related controlled substance” to AM-2201. Like Dr. Cozzi, they criticize the animal studies cited by Dr. Trecki as unreliable and incapable of providing meaningful insight into the effects of AM-2201 on human users. Moreover, Appellants argue that this Court explicitly endorsed their arguments in Allen v. Pennsylvania Engineering Corp.9 In Allen, this Court concluded that the animal studies relied upon by the plaintiffs were “unreliable” and incapable of “furnish[ing] a scientifically valid basis for the conclusion” that the plaintiffs wished to draw.10 In effect, Appellants ask us to do the same here.
We decline to do so. Allen concerned the admission of expert testimony at trial—this is a sentencing case. “[T]he appropriate standard regarding the admissibility of evidence at sentencing is substantially lower than that governing admissibility at trial.”11 Under the Sentencing Guidelines, evidence admitted during sentencing need not meet the Daubert standard;12 rather it need only have “sufficient indicia of reliability to support its probable accuracy.”13 “This court has interpreted
Indeed, Appellants do not appear to take issue with the methods or results of the studies—but instead with inferences the district court drew from them concerning the effects of AM-2201 on human users. This argument goes to the sufficiency of the evidence, not its reliability. Our review of such a challenge is limited. The district court‘s conclusion that THC is the “most closely related controlled substance” to AM-2201 represents a finding of fact.16 “We review the district court‘s findings of fact at sentencing for clear error....” 17 “The court will find clear error ‘only if, based on the entire evidence, the court is left with the definite and firm conviction that a mistake has been committed.’ ”18 “If, after reviewing the record, the district court‘s view of the evidence is plausible, the district court‘s decision must be affirmed even if the judges on this Court, sitting as the trier of fact would have weighed the evidence differently.”19
By this metric, we must affirm the district court‘s conclusion that THC is the “most closely related controlled substance” to AM-2201. It is significant that the district court gave this matter studied attention. It held a day-long evidentiary hearing during which two experts testified at length.20 Both sides were allowed to present scientific evidence and cross-examine the other side‘s expert. After carefully considering all of this evidence, the district court issued a well-reasoned oral decision. While its inferences based upon the animal studies are debatable, nothing in the record leaves us with “the definite and firm conviction that a mistake has been committed.” To the contrary, we agree with the district court that the assertion that we ought “compare an isolated chemical with a leafy green substance” seems implausible on its face—an uncertainty here not dispelled. Appellants sprayed AM-2201 onto a leafy herb to create Mr. Miyagi. Just as THC is the active ingredient in the leafy plant of marijuana, AM-2201 was the active ingredient in Mr. Miyagi. Indeed, any contention that the 1400 kilograms of AM-2201 that Appellants admitted to possessing would have been used to produce only 1400 kilograms of Mr. Miyagi—a product intended to mimic marijuana—is defied by the record; it reflects that the various participants in the conspiracy would have used this quantity of AM-2201 to produce at least twenty times as much Mr. Miyagi.
To the extent Appellants challenge the district court‘s reliance on the 1:167 ratio for converting THC into marijuana, their arguments are similarly unavailing. Even though both experts testified that the 1:167 ratio has no scientific basis, this Court has squarely held that district courts are not required to engage in “a piece-by-piece analysis of the empirical grounding behind each part of the sentencing guidelines” and ignore those parts that do not pass empirical muster.22 We fully agree with the Seventh Circuit that a rule to the contrary would render “sentencing hearings ... unmanageable, as the focus shifts from the defendant‘s conduct to the ‘legislative’ history of the guidelines.”23 As we have said before, “[e]mpirically based or not, the Guidelines remain the Guidelines. It is for the Commission to alter or amend them.”24
B.
Appellants’ next claim is that the district court did not recognize its discretion under Kimbrough v. United States to vary from the 1:167 ratio for converting THC into marijuana. In Kimbrough, the Supreme Court held that district courts have discretion to vary from the Sentencing Guidelines based solely upon policy disagreement.25 And a defendant “is entitled to have his sentence set by a judge aware of the discretion that Kimbrough has announced.”26 That is, a district judge is never required to vary under Kimbrough,27 but every defendant is entitled to be sentenced by a judge who knows that she could vary under Kimbrough if
Appellants argue that the district court‘s comments during sentencing indicate that it did not appreciate its discretion to vary under Kimbrough. Three sets of comments are relevant: First, prior to the evidentiary hearing on Appellants’ Kimbrough objection, the district court said the following:
The Court would tell counsel, just so you know how the Court is leaning, that although the Court might be persuaded, the Court is of the mind that the tables in the sentencing guidelines are what they are, and that that issue may be an issue for a higher court. And I definitely would allow everyone to make their record on that issue, but that my leaning at this point in the morning, before I‘ve heard the evidence, is not to vary or depart from those sentencing guidelines as they‘re written, or the chart as it‘s written in the sentencing guideline manual, because I‘m just the district court judge.
Second, during the direct examination of Dr. Cozzi, the district court made this comment: “There seems to be no rhyme or reason to any of the stuff in the guidelines as to how the equivalent is to marijuana. It all seems to be a relativity type of assessment made by Congress to show the relative harm of these drugs.”29 And third, in ruling on Appellants’ Kimbrough objection, the district court gave this explanation:
The defendants have relied on the Kimbrough case in urging the Court to throw out this guideline. This Court will not do so for several reasons.
First of all, the sentencing guidelines are the expression of Congress that this is what should be done. The Court acknowledges that the ratios in the sentencing guidelines are often arbitrary and present a relative—by converting everything to marijuana, they seek to outline the relative harm of certain drugs.
In Kimbrough, what the Court—what the Supreme Court and the Court was doing was comparing one ratio for one drug to another ratio for another drug and pointing out the unfairness of those two ratios. In this case that‘s not what the defendants have asked us to do. They have simply asked us to throw out the ratio of 1:167 based on its arbitrary nature, and this Court would decline to do so.30
On this record, it is unclear whether the district court properly understood its discretion under Kimbrough. On the one hand, the district court said that it “might be persuaded” to depart and ultimately “decline[d] to do so,” rather than saying that it did not have the authority to do so. There is also no question that the district court was aware of Kimbrough, and had read the opinion.31 But on the other hand,
But we need not resolve this question. Harmless error review applies when a district court fails to recognize its authority to vary under Kimbrough.34 The Government has a “heavy burden” in demonstrating that a sentencing error is harmless,35 but it has met this burden here. Unlike past cases involving this type of error, there is nothing in the record to indicate that the district court was inclined to vary from the 1:167 ratio or pronounce a lesser sentence. The district court did not say that “the outcome [likely] would have been different” if it had discretion36 or suggest that it was “hamstrung” by its lack of discretion.37 Nor did it even say that it was “troubled” by Appellants’ sentences.38 To the contrary, the district court repeatedly commented on the “seriousness of the offense” and declined to accept the extent of the Government‘s recommended § 5K1.1 departures. The district court also explicitly endorsed the 1:167 ratio on at least two occasions, commenting both times that it was designed to capture the “relative harm” of THC as compared to marijuana. Even if the district court erred, we are confident that it would have imposed the same sentence.
C.
Appellants’ third claim is that the district court considered non-assistance-related factors in reducing the extent of their § 5K1.1 departures. In United States v. Desselle, this Court held “that the extent of a § 5K1.1 or § 3553(e) departure must be based solely on assistance-related concerns.”39 Appellants argue that an exchange during sentencing demonstrates that the district court ignored this rule. Following the pronouncement of Green‘s sentence, his counsel asked the district court why it had chosen to depart 30% from the top of his guideline range when the Government had recommended a 50% departure from the bottom of his guideline range. The district court gave the following explanation:
The Court has not accepted that recommendation for the low end of the guidelines.
As the Court has noted, I am struck by the seriousness of the offense. I am struck by the harm, both potential and actual, from what were very reckless
actions on the part of the defendant. It was reckless actions taken solely for the purpose of making a large amount of money. It was a huge risk taken by the defendants which didn‘t work out so well.
Appellants argue that this comment clearly demonstrates that the district court based the extent of their § 5K1.1 departures on non-assistance-related factors.
The Government does not argue otherwise. Conceding that the district court considered non-assistance-related factors, the Government asserts that Desselle should be read as imposing a “one-way ratchet.”40 That is, the Government argues that Desselle only prohibits a district court from considering non-assistance-related factors when increasing the extent of a defendant‘s § 5K1.1 departure, not when limiting the extent of a defendant‘s § 5K1.1 departure. Although this argument may find support in case law from other circuits,41 it finds none in this Court‘s case law. In Desselle, this Court reasoned that the plain language of § 5K1.1 prohibits a district court from considering non-assistance-related factors in determining the extent of a § 5K1.1 departure.42 There is nothing in the plain language of § 5K1.1 that hints at any distinction between increasing and decreasing the extent of a § 5K1.1 departure. The relevant portions of this provision are phrased in absolute terms—just like this Court‘s holding in Desselle. Accordingly, we are bound by this Court‘s previous statement of the law.43
That said, we again conclude that any error committed by the district court was harmless. “The Guidelines set out a three-part framework for the imposition of sentences: the district court (1) calculates the advisory sentencing range; (2) considers the specific offender characteristics and grounds for departure enumerated in the Guidelines; and (3) weighs the applicable factors in
D.
In the alternative, Appellants claim that the § 5K1.1 departures awarded by the district court were unreasonably small given their substantial assistance to the Government. This Court, however, lacks jurisdiction over an unadorned challenge to the extent of a § 5K1.1 departure.46 As we held in Hashimoto, “[d]istrict courts have almost complete discretion to determine the extent of a departure under § 5K1.1. The only ground on which the defendant can appeal the extent of a departure is that the departure was a violation of law.”47 Appellants cannot evade this rule by framing the district court‘s failure to award bigger departures as an error of law. Unlike other phases of the sentencing process, we do not review the district court‘s decision to limit a § 5K1.1 departure for reasonableness. The district court is vested with complete discretion to determine the size of such a departure, as long as it does not commit an independent violation of law. Other than the Desselle claim discussed above, Appellants do not allege such an independent violation—only that their departures were too small.
E.
Appellants’ final claim is that the district court committed clear error in balancing the
III.
For the reasons stated above, we AFFIRM.
